prednisolone has been researched along with Benign Fibrous Mesothelioma in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takahashi, H | 1 |
| Ohkawara, H | 1 |
| Ikeda, K | 1 |
| Harada-Shirado, K | 1 |
| Furukawa, M | 1 |
| Sukegawa, M | 1 |
| Shichishima-Nakamura, A | 1 |
| Noji, H | 1 |
| Wakamatsu, S | 1 |
| Tasaki, K | 1 |
| Suzuki, H | 1 |
| Ogawa, K | 1 |
| Takeishi, Y | 1 |
1 other study available for prednisolone and Benign Fibrous Mesothelioma
| Article | Year |
|---|---|
Pleural solitary fibrous tumor complicated with autoimmune hemolytic anemia.
Topics: Administration, Oral; Aged; Anemia, Hemolytic, Autoimmune; Diagnosis, Differential; Dose-Response Re | 2014 |